Promoting axonal rewiring to improve outcome after stroke

Laboratories for Neuroscience Research in Neurosurgery and F.M. Kirby Neurobiology Program, Children's Hospital, USA.
Neurobiology of Disease (Impact Factor: 5.08). 11/2009; 37(2):259-66. DOI: 10.1016/j.nbd.2009.11.009
Source: PubMed


A limited amount of functional recovery commonly occurs in the weeks and months after stroke, and a number of studies show that such recovery is associated with changes in the brain's functional organization. Measures that augment this reorganization in a safe and effective way may therefore help improve outcome in stroke patients. Here we review some of the evidence for functional and anatomical reorganization under normal physiological conditions, along with strategies that augment these processes and improve outcome after brain injury in animal models. These strategies include counteracting inhibitors of axon growth associated with myelin, activating neurons' intrinsic growth state, enhancing physiological activity, and having behavioral therapy. These approaches represent a marked departure from the recent focus on neuroprotection and may provide a more effective way to improve outcome after stroke.

Download full-text


Available from: S. Thomas Carmichael, Mar 11, 2014
  • Source
    • "Compared to rodents, primates possess an evolutionally expanded volume of white matter, and white matter damage is a clinically important aspect of several CNS diseases, such as stroke or vascular dementia [39] [40] [41] [42] [43]. This may explain the reasons why many neuroprotectants (e.g. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oligodendrocytes, which are the main cell type in cerebral white matter, are generated from their precursor cells (oligodendrocyte precursor cells: OPCs). However, the differentiation from OPCs to oligodendrocytes is disturbed under stressed conditions. Therefore, drugs that can improve oligodendrocyte regeneration may be effective for white matter-related diseases. Here we show that a vasoactive peptide adrenomedullin (AM) promotes the in vitro differentiation of OPCs under pathological conditions. Primary OPCs were prepared from neonatal rat brains, and differentiated into myelin-basic-protein expressing oligodendrocytes over time. This in vitro OPC differentiation was inhibited by prolonged chemical hypoxic stress induced by non-lethal CoCl2 treatment. However, AM promoted the OPC differentiation under the hypoxic stress conditions, and the AM receptor antagonist AM22-52 canceled the AM-induced OPC differentiation. In addition, AM treatment increased the phosphorylation level of Akt in OPC cultures, and correspondingly, the PI3K/Akt inhibitor LY294002 blocked the AM-induced OPC differentiation. Taken together, AM treatment rescued OPC maturation under pathological conditions via an AM-receptor-PI3K/Akt pathway. Oligodendrocytes play critical roles in white matter by forming myelin sheath. Therefore, AM signaling may be a promising therapeutic target to boost oligodendrocyte regeneration in CNS disorders. Copyright © 2015. Published by Elsevier B.V.
    Stem Cell Research 05/2015; 81(1). DOI:10.1016/j.scr.2015.05.001 · 3.69 Impact Factor
  • Source
    • "However, recent studies demonstrate that inosine has neuroprotective, cardioprotective and immunomodulatory effects. Inosine increases neuronal survival and neurite outgrowth in vitro, enhances axon regeneration and axonal sprouting after damage of the central nervous system, and promotes recovery in rodent models of stroke and focal brain trauma123. Administration of inosine improves myocardial function during acute left ventricular failure and protects myocardial and endothelial function after heart transplantation45. Inosine also augments mast-cell degradation, suppresses macrophage, lymphocyte and neutrophil activation, and attenuates inflammatory diseases67. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inosine, a breakdown product of adenosine, has recently been shown to exert immunomodulatory and neuroprotective effects. We show here that the oral administration of inosine has antidepressant-like effects in two animal models. Inosine significantly enhanced neurite outgrowth and viability of primary cultured neocortical neurons, which was suppressed by adenosine A1 and A2A receptor agonists. Oral administration of inosine to mice transiently increased its concentration in the brain and enhanced neuronal proliferation in the dentate gyrus, accompanied by phosphorylation of mitogen-activated protein kinase and increase in transcript level of brain-derived neurotrophic factor. In stress models, oral inosine prevented an increase in immobility time in forced swim test after chronically unexpected stress and mitigated a reduction in sucrose preference after chronic social defeat stress. These results indicate that oral administration of inosine has the potential to prevent depressive disorder via adenosine receptors.
    Scientific Reports 02/2014; 4:4199. DOI:10.1038/srep04199 · 5.58 Impact Factor
  • Source
    • "Neurons display another, organizational form of growth associated with axonal and dendritic pathfinding and elaboration of new neuronal arbors. Organizational growth is normally restricted to initial neuronal differentiation, but it also occurs in fully differentiated neurons under certain situations, including puberty, insect metamorphosis, and seasonal changes in bird song control centers, and in response to injury, stroke, or neurological disease (Levine and Truman, 1982; Finger and Almli, 1985; Brenowitz, 2004; Blakemore and Choudhury, 2006; Benowitz and Carmichael, 2010). Mature neurons vary widely in their capacities to undergo organizational growth (Holm and Isacson, 1999; Goldberg and Barres, 2000), and the factors contributing to these differences are poorly understood. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although the growth capacity of mature neurons is often limited, some neurons can shift through largely unknown mechanisms from stable maintenance growth to dynamic, organizational growth (e.g. to repair injury, or during development transitions). During insect metamorphosis, many terminally differentiated larval neurons undergo extensive remodeling, involving elimination of larval neurites and outgrowth and elaboration of adult-specific projections. Here, we show in the fruit fly, Drosophila melanogaster (Meigen), that a metamorphosis-specific increase in insulin signaling promotes neuronal growth and axon branching after prolonged stability during the larval stages. FOXO, a negative effector in the insulin signaling pathway, blocked metamorphic growth of peptidergic neurons that secrete the neuropeptides CCAP and bursicon. RNA interference and CCAP/bursicon cell-targeted expression of dominant-negative constructs for other components of the insulin signaling pathway (InR, Pi3K92E, Akt1, S6K) also partially suppressed the growth of the CCAP/bursicon neuron somata and neurite arbor. In contrast, expression of wild-type or constitutively active forms of InR, Pi3K92E, Akt1, Rheb, and TOR, as well as RNA interference for negative regulators of insulin signaling (PTEN, FOXO), stimulated overgrowth. Interestingly, InR displayed little effect on larval CCAP/bursicon neuron growth, in contrast to its strong effects during metamorphosis. Manipulations of insulin signaling in many other peptidergic neurons revealed generalized growth stimulation during metamorphosis, but not during larval development. These findings reveal a fundamental shift in growth control mechanisms when mature, differentiated neurons enter a new phase of organizational growth. Moreover, they highlight strong evolutionarily conservation of insulin signaling in neuronal growth regulation.
    Biology Open 12/2013; 3(1). DOI:10.1242/bio.20136437 · 2.42 Impact Factor
Show more